Free signup for more
- Track your favorite companies
- Receive email alerts for new filings
- Personalized dashboard of news and more
- Access all data and search results
Filing tables
PDLI similar filings
- 14 Mar 12 PDL BioPharma Completes Regular Quarterly Dividend Payment
- 13 Mar 12 Regulation FD Disclosure
- 8 Mar 12 PDL BioPharma Provides First Quarter 2012 Royalty Revenue Guidance of $77 Million
- 6 Mar 12 Regulation FD Disclosure
- 5 Mar 12 Other Events
- 28 Feb 12 Regulation FD Disclosure
- 23 Feb 12 PDL BioPharma Announces Fourth Quarter and Full Year 2011 Financial Results
Filing view
External links
Exhibit 99.1
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide1.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide2.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide3.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide4.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide5.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide6.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide7.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide8.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide9.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide10.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide11.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide12.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide13.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide14.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide15.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide16.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide17.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide18.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide19.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide20.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide21.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide22.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide23.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide24.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide25.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide26.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide27.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide28.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide29.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide30.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide31.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide32.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide33.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide34.jpg)
![](https://capedge.com/proxy/8-K/0001437749-12-002034/slide35.jpg)